NL-OMON52513招募中不适用
Exploring underlying mechanisms of paediatric growth disorders using human ex vivo growth plates. - Growth plate collection during routine epiphysiodesis
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •Male or female pediatric patients (< 18 years of age) with idiopathic or
- •familiar tall stature with a predicted adult height > 205 cm (boys) or > 185 cm
- •(girls), and/or evidence of syndromic condition with predisposition for tall
- •Male or female pediatric patients undergoing PE because of idiopathic or
- •post-traumatic limb length discrepancy or transgender patients (male to female)
- •who have a predicted adult height in the normal male range but choose to
- •undergo epiphysiodesis to prevent female tall stature.
排除标准
- •General or other standard contra-indications for PE surgery.
- •Inability to read Dutch and/or verbalize understanding of the study information
研究者
相似试验
已完成
不适用
Growth and development of the term infants with apnea in otherwise healthy: A prospective observational studyApnea in the otherwise healthy, term infantsJPRN-UMIN000045589ational Hospital Organization Miyakonojo Medical Center20
进行中（未招募）
1 期
Antibiotics after drainage of perianal abscess to avoid fistula formatioAbscess and anal fistulasEUCTR2019-001002-18-ESHospital Universitari Germans Trias i Pujol210
招募中
不适用
The pathophysiological analysis of abnormal growth hormone signalingPatients with short stature, tall stature, acromegaly, or gigantism, patients without these diseases as a controlJPRN-UMIN000009931Kobe University Graduate School of Medicine, Kobe, Japan200
已完成
不适用
Investigation of the pathogenesis and development of new treatments for autoimmune diseases, such as systemic lupus erythematosusRheumatoid arthritisJPRN-UMIN000007012Saitama Medical Center, Saitama Medical Universitity20
进行中（未招募）
不适用
Growth Retardation in Children With Special Pathological Conditions or DiseaseGrowth Disorders, Growth RetardationEUCTR2004-002991-40-Outside-EU/EEAPfizer Inc46